Untypable human papillomavirus infection and risk of cervical intraepithelial neoplasia among women with abnormal cervical cytology

Journal of Medical Virology

Volumn 86, Issue 7, 2014, Pages 1145-1152

  Spinillo, Arsenio ^a   Gardella, Barbara ^a   Roccio, Marianna ^a   Alberizzi, Paola ^a   Silini, Enrico Maria ^b   Dal Bello, Barbara ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; Colposcopy; Human papillomavirus

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS TYPING; WART VIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLASSIFICATION; COMPLICATION; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PATHOLOGY; RISK ASSESSMENT; VIROLOGY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK ASSESSMENT; YOUNG ADULT;

EID: 84899939388     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23938     Document Type: Article

References (24)

1. ALTS Group. 2003. A randomized trial on the management of low grade squamous intraepithelial lesion cytological interpretations. Am J Obstet Gynecol 188:1393-1400.
2. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, WHO International Agency for Research on Cancer Monograph Working Group. 2009. A review of human carcinogens-Part B. Biological agents. Lancet Oncol 10:321-322.
3. Castle PE, Gage JC, Wheeler CM, Schiffman M. 2011. The clinical meaning of cervical intraepithelial neoplasia grade 1 biopsy. Obstet Gynecol 118:1222-1229.
4. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E. 2004. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 57:68-72.
5. De Sanjose S, Quint WGV, Alemany L, Retrospective International Survey and HPV Time Trends Study Group. 2010. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 11:1048-1056.
6. Dickson EL, Vogel RI, Bliss RL, Downs LS Jr. 2013. Multiple type human papillomavirus (HPV) infections: A cross-sectional analysis of the prevalence of specific types in 309, 000 women referred for HPV testing at the time of cervical cytology. Int J Gynecol Cancer 23:1295-1302.
7. Geraets D, Alemany L, Guimera N, de Sanjose S, de Koning M, Molijn A, Jenkins D, Bosch X, Quint W, on behalf of the RIS HPV TT study group. 2012. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer. J Pathol 228:534-543.
8. Giuliano AR, Lazcano-Ponce E, Villa LL, Flores R, Salmeron J, Lee JH, Papenfuss MR, Abrahamsen M, Jolles E, Nielson CM, Baggio ML, Silva R, Quiterio M. 2008. The human papillomavirus infection in men study: Human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 17:2036-2043.
9. Gravitt PE, Coutlee F, Iftner T, Sellors JW, Quint WG, Wheeler CM. 2008. New technologies in cervical cancer screening. Vaccine 26:K42-K52.
10. Guimerà N, Lloveras B, Alemany L, Iljazovic E, Shin HR, Jung-Il S, de Sanjose S, Jenkins D, Bosch FX, Quint W. 2013. Laser capture microdissection shows HPV 11 as both a causal and coincidental infection in cervical cancer specimens with multiple HPV types. Histopathology 63:287-292.
11. Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. 2013. Five year risk of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative Pap results. J Low Genit Tract Dis 17:S43-S49.
12. Kirschner B, Schledermann D, Holl K, Rosenlund M, Raillard A, Quint W, Molijn A, Jenkins D, Junge J. 2013. HPV-genotypes in high-grade intraepithelial cervical lesions in Danish women. Acta Obstet Gynecol Scand 92:1032-1040.
13. Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J, Mols J, Van Hoof C, Hardt K, Struyf F, Colau B. 2012. One virus, one lesion. Individual components of CIN lesions contain a specific HPV type. J Pathol 227:62-71.
14. Ramanakumar AV, Goncalves O, Richardson H, Tellier P, Ferenczy A, Coutlée F, Franco EL. 2010. Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women. BMC Infect Dis 10:326-338.
15. Safaeian M, Herrero R, Hildesheim A, Quint W, Freer E, Van Doorn LJ, Porras C, Silva S, González P, Bratti MC, Rodriguez AC, Castle P, Costa Rican Vaccine Trial Group. 2007. Comparison of the SPF10-LiPA system to the hybrid capture 2 assay for detection of carcinogenic human papillomavirus genotypes among 5, 683 young women in Guanacaste, Costa Rica. J ClinMicrobiol 45:1447-1454.
16. Scott JL, Freese J. 2006. Regression models for categorical dependent variables using Stata. 2nd edition. College Station. TX: Stata Press.
17. Sichero L, Pierce Campbell CM, Ferreira S, Sobrinho JS, Luiza Baggio M, Galan L, Silva RC, Lazcano-Ponce E, Giuliano AR, Villa LL, HIM Study Group. 2013. Broad HPV distribution in the genital region of men from the HPV infection in men (HIM) study group. Virology 443:214-217.
18. Snijders PJ, van den Brule AJ, Meijer CJ. 2003. The clinical relevance of human papillomavirus testing: Relationship between analytical and clinical sensitivity. J Pathol 201:1-6.
19. Tornesello ML, Duraturo ML, Botti G, Greggi S, Piccoli R, De Palo G, Montella M, Buonaguro L, Buonaguro FM, Italian HPV Working Group. 2006. Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. J Med Virol 78:1663-1672.
20. Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. 2006. Human papillomavirus infection with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 15:1274-1280.
21. van der Marel J, Quint WG, Schiffman M, van de Sandt MM, Zuna RE, Dunn ST, Smith K, Mathews CA, Gold MA, Walker J, Wentzensen N. 2012. Molecular mapping of high grade cervical intraepithelial neoplasia shows etiological dominance of HPV 16. Int J Cancer 131:E946-E953.
22. van Hamont D, van Ham MA, Bakkers JM, Massuger LF, Melchers WJ. 2006. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche linear array HPV genotyping test. J Clin Microbiol 44:3122-3129.
23. Varnai AD, Bollmann M, Bánkfalvi A, Griefingholt H, Pfening N, Schmitt C, Pajor L, Bollmann R. 2007. The spectrum of cervical diseases induced by low risk and undefined-risk HPVs: Implications for patient management. Anticancer Res 27:563-570.
24. Wright TC, Jr. Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, ASCCP-Sponsored Consensus Conference. 2007. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 11:201-222.